Ventas (NYSE:VTR – Get Free Report) posted its quarterly earnings results on Tuesday. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.01, Zacks reports. The firm had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.77 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.88 earnings per share.
Ventas Stock Performance
Shares of NYSE VTR traded down $4.20 during mid-day trading on Tuesday, reaching $83.22. 5,397,959 shares of the company were exchanged, compared to its average volume of 3,632,285. The company’s 50-day simple moving average is $87.67 and its 200-day simple moving average is $86.31. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $42.69 billion, a P/E ratio of 154.12, a P/E/G ratio of 3.39 and a beta of 0.72. Ventas has a twelve month low of $68.15 and a twelve month high of $101.60.
Ventas Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Wednesday, September 30th. Ventas’s dividend payout ratio (DPR) is currently 385.19%.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.
Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.
Read More
- Five stocks we like better than Ventas
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
